Home > Financial Ratios > SHILPA MEDICARE

SHILPA MEDICARE
Core EBITDA Growth

    Back to All Ratios
SHILPA MEDICARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SHILPA MEDICARE
Please provide your vote to see the results

SHILPA MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 111.12-45.132.98-10.5439.62

What is the latest Core EBITDA Growth ratio of SHILPA MEDICARE ?

The latest Core EBITDA Growth ratio of SHILPA MEDICARE is 111.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024111.12
Mar2023-45.13
Mar20222.98
Mar2021-10.54
Mar202039.62

How is Core EBITDA Growth of SHILPA MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2024 111.12
Positive
Mar2023 -45.13
Negative
Mar2022 2.98
Positive
Mar2021 -10.54
Negative
Mar2020 39.62 -

Other Financial Ratios of SHILPA MEDICARE


Compare Core EBITDA Growth ratio of peers of SHILPA MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHILPA MEDICARE ₹6,570.2 Cr 10.2% 6.9% 31% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


SHILPA MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHILPA MEDICARE

10.2%

6.9%

31%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses